Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pluss Advanced Technologies is an Indian advanced materials company focused on phase change materials, specialty polymers, and temperature-control solutions. The company serves multiple end markets, including life sciences and healthcare, where it commercializes temperature-controlled packaging for pharmaceuticals and a passive neonatal cooling device, MiraCradle, for therapeutic hypothermia in birth asphyxia. Beyond healthcare, Pluss also operates in food cold chain, climate technologies, and specialty polymer additives. The business was founded in 1994, expanded into phase change materials in 2007, and was acquired by Carborundum Universal in 2021 while continuing to operate as an active business. For a biotech or healthcare analyst, the key point is that Pluss is not a drug developer but a commercial healthcare-enabling materials and device company built around proprietary PCM-based thermal management technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pluss Advanced Technologies.